$15.80
0.30[1.94%]
At close: May 14
$15.80
0[0.00%]
PreMarket: 5:40PM EDT
Kyverna Therapeutics
(NASDAQ:KYTX)Kyverna Therapeutics Stock (NASDAQ:KYTX), Earnings Estimates, EPS, and Revenue
Kyverna Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS
$-1.120
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Kyverna Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics (KYTX) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Kyverna Therapeutics (NASDAQ:KYTX)?
The Actual EPS was $-1.12, which missed the estimate of $-0.84.
What were Kyverna Therapeutics’s (NASDAQ:KYTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.